Search results for "Progression"

showing 10 items of 1251 documents

On several notions of complexity of polynomial progressions

2021

For a polynomial progression $$(x,\; x+P_1(y),\; \ldots,\; x+P_{t}(y)),$$ we define four notions of complexity: Host-Kra complexity, Weyl complexity, true complexity and algebraic complexity. The first two describe the smallest characteristic factor of the progression, the third one refers to the smallest-degree Gowers norm controlling the progression, and the fourth one concerns algebraic relations between terms of the progressions. We conjecture that these four notions are equivalent, which would give a purely algebraic criterion for determining the smallest Host-Kra factor or the smallest Gowers norm controlling a given progression. We prove this conjecture for all progressions whose ter…

lukuteoriaGowers normsmultiple recurrenceApplied MathematicsGeneral Mathematicspolynomial progressionskombinatoriikkapolynomitDynamical Systems (math.DS)11B30 37A45Host-Kra factorslukujonotFOS: MathematicsMathematics - CombinatoricsCombinatorics (math.CO)dynaamiset systeemitMathematics - Dynamical SystemsErgodic Theory and Dynamical Systems
researchProduct

Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib

2020

Sorafenib is the first multikinase inhibitor demonstrating a survival benefit for patients suffering from advanced hepatocellular carcinoma (HCC). However, 1 issue remains open: what is the factor able to predict which patients will be long survivors?In the present study, we harnessed the potential of conditional survival, aiming at estimating the probability that a patient receiving sorafenib survives for more than 3 years.The present multicentric study was conducted on a cohort of 438 HCC patients. The primary end point was conditional overall survival. Kaplan-Meier survival analysis was used to calculate conditional overall survival probabilities at 3 years.The 3-year conditional surviva…

macro-vascular portal vein invasionMaleCarcinoma HepatocellularAntineoplastic Agentsextra hepatic disease and BCLCsurvivalNLRAntineoplastic AgentCohort Studiesalpha-fetoproteinHumansLymphocyte CountSurvivorsprognostic factorAgedLiver NeoplasmsMiddle AgedSorafenibProgression-Free SurvivalItalyLiver Neoplasmalpha-fetoprotein; extra hepatic disease and BCLC; hepatitis C; macro-vascular portal vein invasion; NLR; prognostic factor; survivalFemaleCohort Studiehepatitis CCarcinoma Hepatocellular ...Liver Neoplasms ...Human
researchProduct

Mathematical modeling and competencies for biology students

2017

International audience; The research aims at introducing modeling tasks with an ultimate goal to engage students more actively into learning mathematics through tasks that are biologically 'colored'. My focus is on the individual progression (if any) of students' mathematical competencies during a sequence of modeling sessions as part of their first year mathematics. My goal is to explore the nature of progression within the competency profile of participating student, the relation between modeling processes and this progression and what transformations are applied in these sets of competencies.

mathematical competenciesMathematical modeling[MATH] Mathematics [math][SHS] Humanities and Social Sciencesprogressiontasks[MATH]Mathematics [math][SHS]Humanities and Social Sciences
researchProduct

Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment

2016

Cardiorenal syndrome type 4 (CRS type 4), or chronic renocardiac syndrome, has been defined as "chronic abnormalities in renal function leading to cardiac disease" and recognizes the extreme burden of cardiovascular disease (CVD) risk in patients with chronic kidney disease (CKD). CKD is common and increasingly recognized as a risk factor for CVD. Even though the treatment for CVD has dramatically improved over the past decades, it still takes responsibility for up to 50% of deaths in CKD patients. For this reason, patients with CKD should be thoroughly evaluated for cardiovascular risk factors that require careful management, given the significant burden of CRS type 4 on the healthcare sys…

medicine.medical_specialty030232 urology & nephrologyRenal functionCardiorenal syndromeDisease030204 cardiovascular system & hematologyurologic and male genital diseasesLeft ventricular hypertrophyAtherosclerosis; Cardiorenal syndrome type 4; Cardiovascular risk; Chronic kidney disease; Hypertension; Left ventricular hypertrophy; Atherosclerosis; Cardio-Renal Syndrome; Disease Progression; Humans; Hypertension; Hypertrophy Left Ventricular; Renal Dialysis; Renal Insufficiency Chronic; Risk Factors; Internal Medicine03 medical and health sciences0302 clinical medicineRenal DialysisRisk FactorsInternal medicineChronic kidney diseaseCardiorenal syndrome type 4medicineInternal MedicineHumansIn patientRenal InsufficiencyRenal Insufficiency ChronicRisk factorChronicIntensive care medicineCardio-Renal Syndromebusiness.industryLeft ventricular hypertrophyHypertrophymedicine.diseaseAtherosclerosisCardiovascular riskAtherosclerosis; Cardiorenal syndrome type 4; Cardiovascular riskLeft VentricularRenocardiac SyndromeAtherosclerosiHypertensionCardiologyDisease ProgressionHypertrophy Left VentricularbusinessKidney disease
researchProduct

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.

2019

Background & Aim There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed the performance of PRO-C3 in a large, well-characterised international NAFLD cohort and report the development and validation of 2 novel panels for the diagnosis of advanced fibrosis (F≥3) in NAFLD, including a simplified clinical score which eliminates the need for online calculators. Methods Plasma PRO-C3 levels were determined in a prospectively recruited international cohort of 449 patients with biopsy …

medicine.medical_specialtyADVANCED FIBROSISSCORING SYSTEMPROGRESSIONGastroenterologySTEATOHEPATITIS03 medical and health sciences0302 clinical medicineFibrosisInternal medicineNAFLDBiopsyInternal MedicineImmunology and AllergyMedicineSTEATOSISPRO-C3Stage (cooking)lcsh:RC799-869030304 developmental biologySteatohepatitisRISK0303 health sciencesScience & TechnologyHepatologymedicine.diagnostic_testGastroenterology & Hepatologybusiness.industryFatty liverfibrosisGastroenterologyNASHDIABETES-MELLITUSCHRONIC HEPATITISBiomarkermedicine.disease3. Good healthClinical trialCohortBIOPSYBiomarker (medicine)030211 gastroenterology & hepatologylcsh:Diseases of the digestive system. GastroenterologySteatohepatitisbusinessLife Sciences & BiomedicineResearch ArticleJHEP reports : innovation in hepatology
researchProduct

Current management of atopic dermatitis and interruption of the atopic march.

2003

Treatment of atopic dermatitis requires a comprehensive approach that includes evaluation of potential triggers and education of the patient and family regarding proper avoidance measures. Hydration of the skin and maintenance of an intact skin barrier remain integral to proper management. Although topical corticosteroids have been a mainstay of anti-inflammatory therapy, the newer topical calcineurin inhibitors offer advantages for treatment of this chronic, relapsing disease. Studies aimed at defining optimal combination therapy and early intervention might change the treatment paradigm for atopic dermatitis.

medicine.medical_specialtyAllergyImmunologyCalcineurin InhibitorsAnti-Inflammatory AgentsDiseaseEczema Area and Severity IndexDermatitis AtopicAtopyPrevalenceImmunology and AllergyMedicineHumansSCORADAsthmamedicine.diagnostic_testbusiness.industryCalcineurinDisease ManagementAtopic dermatitismedicine.diseaseSkin CareDermatologyAsthmabody regionsCalcineurinDisease ProgressionDermatologic AgentsbusinessThe Journal of allergy and clinical immunology
researchProduct

Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review.

2010

Introduction Cardiovascular diseases are highly prevalent in patients with chronic kidney disease (CKD), and represent the major hazard for mortality in this population. Anomalies of left ventricular (LV) structure and function are very frequent too among CKD patients, and show a negative impact on cardiovascular prognosis. Methods We searched PubMed for manuscripts regarding left ventricular hypertrophy (LVH) in CKD. Definition of LVH was different according to different studies. Results In patients with end-stage renal disease, the prevalence of LVH is higher than 70%. Studies in patients with less advanced CKD have reported increasing prevalence of LVH along with declining renal function…

medicine.medical_specialtyAnemiaPopulationDiastoleRenal functionDiseaseurologic and male genital diseasesLeft ventricular hypertrophyKidneyRisk AssessmentVentricular Function LeftVentricular Dysfunction LeftRisk FactorsInternal medicinemedicinePrevalenceHumanscardiovascular diseasesIntensive care medicineeducationeducation.field_of_studyLeft ventricular dysfunctionbusiness.industryLeft ventricular hypertrophymedicine.diseaseChronic kidney disease.NephrologyHeart failureChronic DiseaseCardiologyDisease ProgressionKidney Failure ChronicHypertrophy Left VentricularKidney DiseasesbusinessKidney diseaseGlomerular Filtration RateJournal of nephrology
researchProduct

Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (I…

2021

Objectives Clinical staging is widely used in medicine to map disease progression, inform prognosis and guide treatment decisions; in psychiatry, however, staging remains a hypothetical construct. To facilitate future research in bipolar disorders (BD), a well-defined nomenclature is needed, especially since diagnosis is often imprecise with blurred boundaries, and a full understanding of pathophysiology is lacking. Methods Under the auspices of the International Society of Bipolar Disorders, a Task Force of international experts was convened to review, discuss, and integrate findings from the scientific literature relevant to the development of a consensus staging model and standardize a t…

medicine.medical_specialtyBipolar DisorderConsensusHeterogeneous groupTask forceAdvisory CommitteesDisease progressionScientific literaturePrognosisInternational Standard Bibliographic Descriptionmedicine.diseaseTerminologyPsychiatry and Mental healthSDG 3 - Good Health and Well-beingDisease ProgressionmedicineHumansNarrative reviewMedical physicsBipolar disorderPsychologyBiological PsychiatryBipolar Disorders
researchProduct

Progression of Gastric Acid Production in Preterm Neonates: Utilization of In-vitro Method

2018

Background: There have been limited studies done regarding ability to produce gastric acid in preterm infants. Most studies have used in vivo method of assessing gastric pH. Objectives: The objectives of the study was to assess the feasibility of using an in vitro method of measuring gastric pH in babies ≤ 28 weeks gestational age (GA) and determine whether changes in gastric pH differ with gestational age, mode of delivery, and use of antenatal steroids. Design/Methods: Prospective study that enrolled extremely low birth weight (ELBW) babies. Gastric aspirate was collected before feeding. In vitro testing of gastric aspirates for pH were done on days of life 1, 3, 5, 7, 14, and 28 by using…

medicine.medical_specialtyBirth weightCoefficient of variationInvitro methodGastroenterologypH meterprogression of acidity03 medical and health sciences0302 clinical medicine030225 pediatricsInternal medicinemedicinepreterm infantsProspective cohort studygastric pHbusiness.industrylcsh:RJ1-570Gestational ageRepeated measures designlcsh:PediatricsLow birth weight030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthGastric acidrefluxmedicine.symptombusinessFrontiers in Pediatrics
researchProduct

T1HG Bladder Tumours: So Many Papers, Do We Need Them? Yes, We Do!

2009

“How many roads a man must walk on….” and how many papers we must read and write… to put down the final word on the appropriate management of high risk NMI-BC. Although it is more than 20 years that we take notice of promises on biological markers predictive of the behaviour of NMI-BC, till today we can only base our decisions on clinical and pathological data. Consequently, we need exchange of experiences and reports on the outcome of these patients. The aim of the treatment of T1 bladder tumours is to minimize mortality while assuring reduced morbidity and good quality of life. A conservative approach is, obviously, not applicable to all T1HG tumours. We need to identify unequivocal selec…

medicine.medical_specialtyBladder cancerNoticebusiness.industryUrologyGeneral surgerymedicine.diseaseResectionQuality of lifeConcomitantBladder cancer T1 high grade G3 cystectomy conservative treatmentmedicineProper treatmentProgression ratebusinessEuropean Urology
researchProduct